FR3006313B1 - NATURAL COMPOUNDS AND DERIVATIVES THEREOF, THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE AND CARDIOVASCULAR DISEASES, CANCER, AND FOR FOOD OR COSMETIC APPLICATIONS. - Google Patents

NATURAL COMPOUNDS AND DERIVATIVES THEREOF, THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE AND CARDIOVASCULAR DISEASES, CANCER, AND FOR FOOD OR COSMETIC APPLICATIONS. Download PDF

Info

Publication number
FR3006313B1
FR3006313B1 FR1354893A FR1354893A FR3006313B1 FR 3006313 B1 FR3006313 B1 FR 3006313B1 FR 1354893 A FR1354893 A FR 1354893A FR 1354893 A FR1354893 A FR 1354893A FR 3006313 B1 FR3006313 B1 FR 3006313B1
Authority
FR
France
Prior art keywords
treatment
neurodegenerative
cardiovascular diseases
cancer
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR1354893A
Other languages
French (fr)
Other versions
FR3006313A1 (en
Inventor
Catherine Virot
Stephane Desobry
Francoise Chretien
Thierry Oster
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Universite de Lorraine
Original Assignee
Centre National de la Recherche Scientifique CNRS
Universite de Lorraine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique CNRS, Universite de Lorraine filed Critical Centre National de la Recherche Scientifique CNRS
Priority to FR1354893A priority Critical patent/FR3006313B1/en
Publication of FR3006313A1 publication Critical patent/FR3006313A1/en
Application granted granted Critical
Publication of FR3006313B1 publication Critical patent/FR3006313B1/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/52—Esters of acyclic unsaturated carboxylic acids having the esterified carboxyl group bound to an acyclic carbon atom
    • C07C69/587—Monocarboxylic acid esters having at least two carbon-to-carbon double bonds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/62—Carboxylic acid esters

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La présente invention concerne des composés de formule (I) où R1 est choisi parmi le groupe comprenant H, OH, OCH , R est choisi parmi le groupe comprenant H, OH, OCH , au moins l'un de R et R étant le groupe OCH , R est H, OH, R est H, OH, R est une chaîne alkyle, alkényle, comportant de 1 à 4 atomes de carbone, R est une chaîne linéaire alkyle, alkényle, comportant de 1 à 32 atomes de carbone. L'invention concerne également l'utilisation de ces composés pour la prévention ou le traitement de maladies neurodégénératives ou du vieillissement cérébral, de maladies cardiovasculaires ou de cancers.The present invention relates to compounds of formula (I) where R1 is chosen from the group comprising H, OH, OCH, R is chosen from the group comprising H, OH, OCH, at least one of R and R being the group OCH, R is H, OH, R is H, OH, R is an alkyl, alkenyl chain, having from 1 to 4 carbon atoms, R is a linear alkyl, alkenyl chain, having from 1 to 32 carbon atoms. The invention also relates to the use of these compounds for the prevention or treatment of neurodegenerative diseases or of aging of the brain, of cardiovascular diseases or of cancers.

FR1354893A 2013-05-29 2013-05-29 NATURAL COMPOUNDS AND DERIVATIVES THEREOF, THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE AND CARDIOVASCULAR DISEASES, CANCER, AND FOR FOOD OR COSMETIC APPLICATIONS. Expired - Fee Related FR3006313B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR1354893A FR3006313B1 (en) 2013-05-29 2013-05-29 NATURAL COMPOUNDS AND DERIVATIVES THEREOF, THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE AND CARDIOVASCULAR DISEASES, CANCER, AND FOR FOOD OR COSMETIC APPLICATIONS.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1354893A FR3006313B1 (en) 2013-05-29 2013-05-29 NATURAL COMPOUNDS AND DERIVATIVES THEREOF, THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE AND CARDIOVASCULAR DISEASES, CANCER, AND FOR FOOD OR COSMETIC APPLICATIONS.
FR1354893 2013-05-29

Publications (2)

Publication Number Publication Date
FR3006313A1 FR3006313A1 (en) 2014-12-05
FR3006313B1 true FR3006313B1 (en) 2019-12-06

Family

ID=48874362

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1354893A Expired - Fee Related FR3006313B1 (en) 2013-05-29 2013-05-29 NATURAL COMPOUNDS AND DERIVATIVES THEREOF, THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE AND CARDIOVASCULAR DISEASES, CANCER, AND FOR FOOD OR COSMETIC APPLICATIONS.

Country Status (1)

Country Link
FR (1) FR3006313B1 (en)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001026538A (en) * 1999-07-13 2001-01-30 Morinaga & Co Ltd Food and medicine composition containing new capsaicinoid-like substance
JP4560864B2 (en) * 1999-11-30 2010-10-13 味の素株式会社 Analgesics, foods and feeds containing novel capsaicinoid-like substances
ES2193874B1 (en) * 2002-04-03 2005-03-01 Puleva Biotech, S.A. NATURAL AND DERIVATIVE COMPOUNDS OF THESE FOR THE PREVENTION AND TREATMENT OF CARDIOVASCULAR, HEPATIC, RENAL AND COSMETIC DISEASES.
US9399030B2 (en) * 2005-02-01 2016-07-26 Ajinomoto Co., Inc. Topically applied circulation enhancing agent and skin and hair cosmetic and bath agent containing the same
JP4961765B2 (en) * 2006-02-10 2012-06-27 味の素株式会社 Coniferyl derivatives and uses thereof
JP5288397B2 (en) * 2008-02-08 2013-09-11 国立大学法人東京農工大学 Anticancer agents derived from natural ingredients that can be taken orally

Also Published As

Publication number Publication date
FR3006313A1 (en) 2014-12-05

Similar Documents

Publication Publication Date Title
MA43409B1 (en) Polycyclic compounds for use as bruton tyrosine kinase inhibitors
MA34831B1 (en) AMINOINDAN AMIDES WITH HIGH FUNGALITY ACTIVITY AND PHYTOSANITARY COMPOSITIONS
MA37439A1 (en) Cyclic ether bridge dgat1 inhibitors for the treatment of acyl mediated disorders coa-diacylglycerol transferase 1 (dgat1).
MA35920B1 (en) Compounds for the treatment of spinal muscular atrophy
EA201592024A1 (en) SUBSTITUTED 5- (3,5-DIMETHILISOXAZOL-4-IL) -INDOLIN-2-ONE
MA46490A1 (en) Substituted 4'- fluoro-2 '- methyl nucleoside derivatives
EA201691141A1 (en) CONNECTIONS AGAINST CCR6
FR3066761B1 (en) NEW IONIC CHANNEL INHIBITORS
GEP20156315B (en) Oxazoline and isoxazoline derivatives as crac modulators
MA43160B1 (en) New cryptophycin compounds and conjugates, their preparation and therapeutic application
BR112015019437A2 (en) bis (2-indenyl) metallocene complex
PH12015502523A1 (en) Novel (cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazoles
FR3064633B1 (en) NOVEL DITHIOSPIROCETAL COMPOUNDS AND THEIR USE
MA39305A3 (en) Ethynyl derivatives
MA39253B1 (en) Substituted bicyclic heteroaryl compounds used as rxr agonists
MA34291B1 (en) COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING A TUMOR
FR3006313B1 (en) NATURAL COMPOUNDS AND DERIVATIVES THEREOF, THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE AND CARDIOVASCULAR DISEASES, CANCER, AND FOR FOOD OR COSMETIC APPLICATIONS.
MA20150280A2 (en) Arylethynyl derivatives
EA201890769A1 (en) 2,3,4,5-TETRAHYDROPYRIDIN-6-AMINE DERIVATIVES
MA37999B1 (en) Macrolide derivatives, their preparation and their therapeutic use
BR112018010714A8 (en) compounds
EA201170885A1 (en) NEW DERIVATIVES OF THE RETINOIDS OWNING CYTOTOXIC AND / OR ANTIANGIOGENIC PROPERTIES
MA33938B1 (en) 5-alkynyl-PYRIMIDINE
MA54520B1 (en) ANTI-CANCER COMPOUNDS
MA33175B1 (en) RESORCINOL SULFUR DERIVATIVES, THEIR PREPARATION AND THEIR COSMETIC USES

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6

ST Notification of lapse

Effective date: 20200108